000 01256 a2200325 4500
005 20250515114540.0
264 0 _c20080515
008 200805s 0 0 eng d
022 _a1871-5206
024 7 _a10.2174/187152008783961905
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aRucci, Nadia
245 0 0 _aInhibition of protein kinase c-Src as a therapeutic approach for cancer and bone metastases.
_h[electronic resource]
260 _bAnti-cancer agents in medicinal chemistry
_cApr 2008
300 _a342-9 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aAnimals
650 0 4 _aAntineoplastic Agents
_xpharmacology
650 0 4 _aBone Neoplasms
_xprevention & control
650 0 4 _aEnzyme Inhibitors
_xpharmacology
650 0 4 _aHumans
650 0 4 _aNeoplasm Metastasis
_xprevention & control
650 0 4 _aOsteoclasts
_xdrug effects
650 0 4 _aProto-Oncogene Mas
650 0 4 _asrc-Family Kinases
_xantagonists & inhibitors
700 1 _aSusa, Maria
700 1 _aTeti, Anna
773 0 _tAnti-cancer agents in medicinal chemistry
_gvol. 8
_gno. 3
_gp. 342-9
856 4 0 _uhttps://doi.org/10.2174/187152008783961905
_zAvailable from publisher's website
999 _c17892718
_d17892718